Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

PCSK9 Inhibitor [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
0024-5901 Praluent alirocumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2015-07-24
0024-5902 Praluent alirocumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2015-07-24
61755-020 Praluent alirocumab Regeneron Pharmaceuticals, Inc. INJECTION, SOLUTION 2020-12-01
61755-021 Praluent alirocumab Regeneron Pharmaceuticals, Inc. INJECTION, SOLUTION 2020-12-01
72511-393 REPATHA Evolocumab Amgen USA Inc. INJECTION, SOLUTION 2024-11-24
72511-501 REPATHA Evolocumab Amgen USA Inc. INJECTION, SOLUTION 2024-11-24
72511-750 REPATHA Evolocumab Amgen USA Inc. INJECTION, SOLUTION 2018-10-09
72511-760 REPATHA Evolocumab Amgen USA Inc. INJECTION, SOLUTION 2018-10-09



 [EPC] Established Pharmacological Classification 

Loading full table content...